BioGeneration Ventures Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 8
- Investments
- 49
- Portfolio
- 17
- Exits
- 16
BioGeneration Ventures General Information
Description
Founded in 2006, BioGeneration Ventures is a venture capital firm and is based in Naarden, Netherlands. The firm focuses on early stage European biotech, medtech and diagnostics companies. T
Contact Information
Website
www.biogenerationventures.com
Year Founded
2006
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Gooimeer 2-35
- 1411 DC Naarden
- Netherlands
+31 035 000 0000
BioGeneration Ventures Investments (49)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| VectorY (Drug Discovery) | 15-Jun-2021 | Seed Round | 000.00 | Drug Discovery | Pre-Clinical Trials | |
| 0000 00000000 | 26-Apr-2021 | 00000 00000 | 00.000 | Biotechnology | Generating Revenue | 000000000 000 |
| 00000000 | 06-Apr-2021 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 000000 000 00000 |
| 000000 | 24-Nov-2020 | 0000 00000 | 00.000 | Drug Discovery | Startup | 000000 0000000000 00.0 |
| 0000000 | 10-Nov-2020 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000 00000000 |
| 00000 | 03-Jul-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 00000 00000000 |
| 0000000 | 02-Jul-2020 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 000000 000 00000 |
| 000000 0000000 | 12-Jun-2020 | 00000 00000 | 00.000 | Surgical Devices | Generating Revenue | 00000 00000000 |
| Dualyx | 31-Mar-2020 | Seed Round | 00.000 | Biotechnology | Startup | |
| NorthSea Therapeutics | 08-Jan-2020 | Early Stage VC | 0000 | Biotechnology | Clinical Trials - Phase 2 |
BioGeneration Ventures Exits (16)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Staten Biotechnology | 17-Dec-2018 | Merger/Acquisition | 00000 |
| 0000000000 | 18-Oct-2017 | 000000000000000000 | |
| 0000000 | 27-Jun-2017 | 0000000000: 000000 | |
| 0000000 | 01-Apr-2016 | 000 00 00000000 | |
| 000000 000000 | 02-Feb-2016 | 000000000000000000 | 000 |
| 000000 000000 | 14-Oct-2015 | 000000000000000000 | 00.000 |
| 00000000000 | 18-Sep-2015 | 000000000000000000 | 00.00 |
| 0000000 000000 | 07-May-2015 | 000000000000000000 | 000.00 |
| Argenx | 10-Jul-2014 | IPO | 000.00 |
| Simibio | 01-Mar-2011 | Out of Business |
BioGeneration Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore BioGeneration Ventures‘s full profile, request access.
Request a free trialBioGeneration Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialBioGeneration Ventures Team (21)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Arnoud Dijkstra Ph.D | Venture Partner | Naarden, Netherlands | |||
| Daniela Couto Ph.D | Partner | 0 | 0 | 0 | Naarden, Netherlands |
| Oskar Slotboom | Partner | 0 | 0 | 0 | Naarden, Netherlands |
| Robbert van de Griendt | Head of Investor Relations & Impact | 0 | Naarden, Netherlands | ||
| Rianne Ellenbroek Ph.D | Investment Manager, FIRST Fund | 0 | Naarden, Netherlands |
BioGeneration Ventures Co-Investors (53)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| FORBION | 5 | 0 |
|
|
|
| Brabantse Ontwikkelings Maatschappij | 0 | 0 |
|
|
|
| Inkef Capital | 0 | 0 |
|
|
|
| New Science Ventures | 0 | 0 |
|
|
|
| Utrecht Holdings | 0 | 0 |
|
|